Matches in Nanopublications for { ?s ?p "[Lysophosphatidic acid-induced cell invasion and migration were significantly inhibited using either NET1 siRNA or a RhoA inhibitor (C3 exoenzyme), thus indicating the activity of both NET1 and RhoA in gastric cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP711999.RAb1VYsWFPPzrmBQza8hNL7HgAv_7UaocVfZOZmEAEz7U130_assertion description "[Lysophosphatidic acid-induced cell invasion and migration were significantly inhibited using either NET1 siRNA or a RhoA inhibitor (C3 exoenzyme), thus indicating the activity of both NET1 and RhoA in gastric cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711999.RAb1VYsWFPPzrmBQza8hNL7HgAv_7UaocVfZOZmEAEz7U130_provenance.
- NP290050.RA0Ebua-6mBBBQnRRUhnzvwLmiX3JgituNcB9sGoGudP0130_assertion description "[Lysophosphatidic acid-induced cell invasion and migration were significantly inhibited using either NET1 siRNA or a RhoA inhibitor (C3 exoenzyme), thus indicating the activity of both NET1 and RhoA in gastric cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP290050.RA0Ebua-6mBBBQnRRUhnzvwLmiX3JgituNcB9sGoGudP0130_provenance.
- NP721778.RA6ErDcCedd5KUPQgLy00pn_l9uCcaByDarVWubCr7MZ4130_assertion description "[Lysophosphatidic acid-induced cell invasion and migration were significantly inhibited using either NET1 siRNA or a RhoA inhibitor (C3 exoenzyme), thus indicating the activity of both NET1 and RhoA in gastric cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721778.RA6ErDcCedd5KUPQgLy00pn_l9uCcaByDarVWubCr7MZ4130_provenance.
- NP921118.RA2mmyyjaOAnkv9hAT5iylpssmbbr0TRAZZq_CyCgcL5A130_assertion description "[Lysophosphatidic acid-induced cell invasion and migration were significantly inhibited using either NET1 siRNA or a RhoA inhibitor (C3 exoenzyme), thus indicating the activity of both NET1 and RhoA in gastric cancer progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921118.RA2mmyyjaOAnkv9hAT5iylpssmbbr0TRAZZq_CyCgcL5A130_provenance.